Metacrine (MTCR) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free MTCR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Metacrine Short Interest DataCurrent Short Volume129,000 sharesPrevious Short Volume87,400 sharesChange Vs. Previous Month+47.60%Dollar Volume Sold Short$68,499.00Short Interest Ratio / Days to Cover0.3Last Record DateJanuary 31, 2023Outstanding Shares42,570,000 sharesPercentage of Shares Shorted0.30%Today's Trading Volume83,889 sharesAverage Trading Volume225,834 sharesToday's Volume Vs. Average37% Short Selling Metacrine ? Sign up to receive the latest short interest report for Metacrine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMTCR Short Interest Over TimeMTCR Days to Cover Over TimeMTCR Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Metacrine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2023129,000 shares $68,499.00 +47.6%N/A0.3 $0.53 1/15/202387,400 shares $38,115.14 -61.8%N/A0.3 $0.44 12/30/2022228,600 shares $102,389.94 +117.3%N/A0.7 $0.45 12/15/2022105,200 shares $36,820.00 -10.5%N/A0.3 $0.35 11/30/2022117,600 shares $47,639.76 -3.3%N/A0.4 $0.41 11/15/2022121,600 shares $55,388.80 -2.2%N/A0.2 $0.46 Get the Latest News and Ratings for MTCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Metacrine and its competitors with MarketBeat's FREE daily newsletter. 10/31/2022124,300 shares $52,665.91 -10.3%N/A0.2 $0.42 10/15/2022138,500 shares $57,893.00 -15.2%N/A0.3 $0.42 9/30/2022163,400 shares $79,249.00 -54.3%N/A0.3 $0.49 9/15/2022357,400 shares $177,735.02 +6.0%N/A0.7 $0.50 8/31/2022337,200 shares $159,158.40 +17.5%N/A0.7 $0.47 8/15/2022287,100 shares $144,985.50 -36.3%N/A0.8 $0.51 7/31/2022450,400 shares $224,299.20 -6.9%N/A1 $0.50 7/15/2022483,900 shares $260,047.86 -27.5%N/A0.9 $0.54 6/30/2022667,700 shares $333,850.00 -5.3%N/A0.8 $0.50 6/15/2022704,900 shares $326,368.70 -18.0%N/A0.6 $0.46 5/31/2022859,800 shares $430,157.94 -5.8%N/A0.6 $0.50 5/15/2022912,800 shares $412,859.44 +12.9%N/A0.6 $0.45 4/30/2022808,600 shares $350,932.40 -33.7%N/A0.5 $0.43 4/15/20221,220,000 shares $713,700.00 -6.2%N/A0.6 $0.59 3/31/20221,300,000 shares $792,870.00 +98.0%N/A0.6 $0.61 3/15/2022656,500 shares $290,829.50 +41.0%N/A0.2 $0.44 2/28/2022465,600 shares $231,170.40 -20.9%N/A0.1 $0.50 2/15/2022588,600 shares $280,762.20 -30.4%N/A0.2 $0.48 1/31/2022845,800 shares $465,443.74 +15.8%4.6%0.2 $0.55 1/15/2022730,300 shares $411,012.84 -7.3%4.0%0.2 $0.56 12/31/2021788,100 shares $531,337.02 +19.0%5.8%0.2 $0.67 12/15/2021662,100 shares $966,666.00 +22.6%5.1%0.2 $1.46 11/30/2021539,900 shares $712,668.00 +46.6%4.3%0.4 $1.32 11/15/2021368,200 shares $463,932.00 -23.6%2.9%0.3 $1.26 10/29/2021481,800 shares $684,156.00 +199.3%3.9%0.5 $1.42 10/15/2021161,000 shares $561,890.00 +7.7%1.4%0.3 $3.49 9/30/2021149,500 shares $512,785.00 +61.6%1.3%0.7 $3.43 9/15/202192,500 shares $268,250.00 +62.3%0.8%0.5 $2.90 8/31/202157,000 shares $182,400.00 -76.8%0.5%0.4 $3.20 8/13/2021246,000 shares $789,660.00 -16.0%2.1%1.6 $3.21 7/30/2021292,700 shares $825,414.00 -1.0%2.5%1.5 $2.82 7/15/2021295,500 shares $924,915.00 +1.2%2.6%1.5 $3.13 6/30/2021292,100 shares $1.11 million -31.8%2.5%1.5 $3.80 6/15/2021428,200 shares $1.81 million +39.7%3.7%2.3 $4.22Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. MTCR Short Interest - Frequently Asked Questions What is Metacrine's current short interest? Short interest is the volume of Metacrine shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 129,000 shares of MTCR short. Learn More on Metacrine's current short interest. Is Metacrine's short interest increasing or decreasing? Metacrine saw a increase in short interest in January. As of January 31st, there was short interest totaling 129,000 shares, an increase of 47.6% from the previous total of 87,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Metacrine's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Metacrine: Qilian International Holding Group Limited (0.78%), Lumos Pharma, Inc. (5.83%), Oncternal Therapeutics, Inc. (0.52%), Iterum Therapeutics plc (7.50%), Forte Biosciences, Inc. (0.09%), Lisata Therapeutics, Inc. (0.24%), Biora Therapeutics, Inc. (4.33%), Lipocine Inc. (5.41%), TherapeuticsMD, Inc. (0.41%), Bullfrog AI Holdings, Inc. (5.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.19 billion), Snowflake Inc. ($2.35 billion), T. Rowe Price Group, Inc. ($2.14 billion), Coinbase Global, Inc. ($2.14 billion), Paramount Global ($1.99 billion), Etsy, Inc. ($1.76 billion), Lucid Group, Inc. ($1.70 billion), Wayfair Inc. ($1.63 billion), Old Dominion Freight Line, Inc. ($1.61 billion), and CarMax, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Metacrine stock? Short selling MTCR is an investing strategy that aims to generate trading profit from Metacrine as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Metacrine? A short squeeze for Metacrine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MTCR, which in turn drives the price of the stock up even further. How often is Metacrine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MTCR, twice per month. The most recent reporting period available is January, 31 2023. More Short Interest Resources from MarketBeat Related Companies: QLI Short Squeeze LUMO Short Squeeze ONCT Short Squeeze ITRM Short Squeeze FBRX Short Squeeze LSTA Short Squeeze BIOR Short Squeeze LPCN Short Squeeze TXMD Short Squeeze BFRG Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MTCR) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing